Genomic Translation for Amyotrophic Lateral Sclerosis Care
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Matthew Harms, MD
Columbia University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- the University of Edinburgh
Edinburgh, United Kingdom
- Cedar Sinai Medical Center
Los Angeles, California, United States
- University of Colorado School of Medicine
Aurora, Colorado, United States
- Univeristy of Michigan
Ann Arbor, Michigan, United States
- University of Minnesota
Minneapolis, Minnesota, United States
- Washington University
St Louis, Missouri, United States
- Columbia University
New York, New York, United States
- Duke University
Durham, North Carolina, United States
- Oregon Health & Sciences University
Portland, Oregon, United States
- Penn State College of Medicine
Hershey, Pennsylvania, United States
- University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
- Houston Methodist Neurological Institute
Houston, Texas, United States
- University of Utah
Salt Lake City, Utah, United States
- University of Washington
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Jun 2016
- Primary completion
- 27 Jul 2021
- Completion
- 29 Jun 2022
- Last update posted
- 19 Aug 2022
- Registered enrollment
- 254
- Registry id
- NCT02795897
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.